Fatty acids, very long chained
(VLCFA, C 22 (Docosanoic acid), C 24 (Tetracosanoic acid), C 26 (Hexacosanoic acid))
| Material: | 5 ml serum |
| Methods: | Hochleistungsflüssigkeitschromatographie (HPLC) → Hochleistungsflüssigkeitschromatographie (HPLC) | Reference range | Please refer to findings report. |
| Indication | Suspicion of adrenoleucodystrophy, Zellweger-syndrome (Cerebro-hepato-renal syndrome), deficiency syndrome in premature babies. |
| Please note | The adrenoleucodystrophy is an X-chromosomal hereditary illness, which can cause adrenal insufficiency or CNS-symptoms (visual defects, hearing problems, para- or hemiparesis, apraxia, aphasia and others). |
| External services | ja Medizinisches Labor Bremen |
More Results for the letter F
- Factor II activity (FACT01)
- Prothrombin
- Factor II mutation (FACT02)
- Prothrombin mutation G20210A
- Factor IX activity (FACT11)
- Factor V activity (FACT03)
- Factor V mutation Leiden (FACT04)
- Mutation: G1691A
- Factor VII activity (FACT05)
- Factor VIII activity (FACT06)
- Factor VIII inhibitor (FACT10)
- Factor VIII ristocetin cofactor (von Willebrand factor activity) (FACT08)
- vWF:activity
- Factor VIII von Willebrand factor antigen (FACT07)
- vWF:Ag
- Factor VIII von Willebrand multimers (FACT09)
- Factor X activity (FACT12)
- Factor XI activity (FACT13)
- Factor XII activity (FACT14)
- Hageman-Factor
- Factor XIII activity (FACT15)
- Syn.: fibrin stabilising factor
- Factor–II–activity (FAK2)
- Prothrombin
- Factor-II-mutation (FAK2GM)
- Prothrombin mutation G20210A
- Factor-IX-activity (FAK9)
- Factor-V-activity (FAK5)
- Factor-V-mutation Leiden (FAK5GM)
- Mutation: G1691A
- Factor-VII-activity (FAK7)
- Factor-VIII-activity (FAK8)
- Factor-VIII-inhibitor (FAK8IN)
- Bethesda assay
- Factor-X-activity (FAK10)
- Factor-XI-activity (FAK11)
- Factor-XII-activity (FAK12)
- Hageman factor
- Factor-XIII-activity (FAK13)
- Fibrin-stabilizing factor
- Fasciola hepatica (FASCI, FASCG)
- Common liver fluke
- Fat, total in stool (FETT1)
- Fatty acids, long-chained (LAFS)
- LCFA